News

This is Ask An Expert, where every weekday at 9:20am, KCBS Radio is giving you direct access to top experts in various fields. Today: Gene-editing technology allows scientists to work with DNA in unprecedented ways, but there are larger scientific...

For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.

Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...

Pronatalism is an old idea with roots in eugenics and nationalism, that is now fashionable among far-right influencers and policymakers. They talk...

This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By David Cyranoski, Nature | 09.10.2014

A Japanese patient with a debilitating eye disease is about to become the first person to be treated with induced...

By David Jensen, California Stem Cell Report | 09.10.2014
BERKELEY, Ca. -- Directors of the California stem cell agency today approved a measure aimed at easing conflicts of interest...
By Nina Liss-Schultz, RH Reality Check | 09.10.2014
Untitled Document

San Francisco might become the first city to explicitly condemn sex-selective abortion bans, if a resolution introduced Tuesday...

By Editorial, Nature | 09.09.2014
Untitled Document

It is perhaps unexpected that the United States — the oft-lampooned home of patents on peanut-butter-and-jelly sandwiches and...

By Julia Belluz, Vox | 09.09.2014

All his life, Neil Schwartzman searched for his biological family. He was adopted in 1960 at 10 days old, and...

By The Yomiuri Shimbun, The Yomiuri Shimbun | 09.09.2014

One out of about 27 babies born in Japan in 2012 was conceived by in vitro fertilization, a sharp increase...

By Bangkok Post, Bangkok Post | 09.09.2014

A surrogate mother who had second thoughts appealed for help from authorities after becoming the target of threats and intimidation...

By Dr. Ted Morrow, BioNews | 09.08.2014

The regulatory path to clinical trials of mitochondrial replacement therapy (MRT) was recently debated in the House of Commons...